Skip to main content
Mary (Mansour) Riwes, DO, Hematology, Ann Arbor, MI, University of Michigan Medical Center

MaryMansour(Mansour)RiwesDO

Hematology Ann Arbor, MI

Physician

Are you Dr. Riwes?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 18 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Mary (Mansour) Riwes, DO is a hematologist in Ann Arbor, Michigan. She is currently licensed to practice medicine in Michigan and Ohio. She is affiliated with University of Michigan Medical Center.

Education & Training

  • University of Florida College of Medicine Jacksonville
    University of Florida College of Medicine JacksonvilleFellowship, Medical Oncology, 2013
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2007 - 2010
  • NYIT College Of Osteopathic Medicine
    NYIT College Of Osteopathic MedicineClass of 2007
  • NYIT College Of Osteopathic Medicine
    NYIT College Of Osteopathic MedicineClass of 2007

Certifications & Licensure

  • MI State Medical License
    MI State License 2013 - 2026
  • OH State Medical License
    OH State License 2007 - 2010
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Publications & Presentations

PubMed

Press Mentions

  • NIH Award Supports Sickle Cell Disease Treatment in Malawi, NCI Outstanding Investigator Awards Granted for Research in Hematology, and More
    NIH Award Supports Sickle Cell Disease Treatment in Malawi, NCI Outstanding Investigator Awards Granted for Research in Hematology, and MoreDecember 1st, 2020
  • Rogel Team Receives $11.2M to Leverage the Microbiome Against GVHD
    Rogel Team Receives $11.2M to Leverage the Microbiome Against GVHDOctober 21st, 2020
  • Potato Starch Supplements Could Be Solution to Bone Marrow Transplant Complications
    Potato Starch Supplements Could Be Solution to Bone Marrow Transplant ComplicationsOctober 22nd, 2023

Hospital Affiliations